Safety and efficacy of electro-thumbtack needle for acute mountain sickness patients: a protocol of a randomized, single-blinded, and placebo-controlled study
BMC Complementary Medicine and Therapies · 2024
DOI: 10.1186/s12906-024-04655-3 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift BMC Complementary Medicine and Therapies, 2024. Verfasst von Xin Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China. Hauptthemen laut MEDLINE: Altitude Sickness. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Basic Scientific Research Business Independent Selection Program of the China Academy of Chinese Medical Sciences, The Science and Technology Innovation Project of China Academy of Chinese Medical Sciences, The National Key Research and Development Program of China.
Abstract (Originalsprache)
BACKGROUND: Acute mountain sickness (AMS) is considered the most common altitude sickness. It can be detrimental to the health of tourists who rapidly ascend high mountains, and can also impair the performance of individuals who move to the plateau for work or education. Acupuncture has been shown to improve AMS as a simple, safe, and effective nonpharmacological method, in case electro-thumbtack needle (ETN) is a more convenient form of acupuncture for both doctor and patient. There are no studies validating the effectiveness of electro-thumbtack needle in improving symptoms in participants with AMS. In this study, we will conduct a randomized controlled trial to evaluate the clinical efficacy and safety of electro-thumbtack needle in participants with AMS. Our hypothesis is that electro-thumbtack needle is safe and effective in treating participants with AMS. METHODS: This study is a single-center, randomized, single-blinded, and placebo-controlled study involving at least 114 participants who were diagnosed with AMS. The participants randomly assigned in a 1:1 ratio to the electro-thumbtack needle group and the sham acupuncture group. The treatment protocol involved stimulation of seven predefined acupuncture points, including Zhong Wan (RN12), bilateral Nei Guan (PC6), bilateral He Gu (LI4), and bilateral Tai Yang (EX-HN5), for approximately one minute each, with continuous application over 48 h. The primary outcome was improvement in 2018 Lake Louise score (LLS) after 48 h of treatment. Secondary outcome indicators included the incidence of participants with moderate-to-severe AMS (AMS > 5)and AMS, the LLS, visual analogue scale of headache, clinical functioning scores, the Groningen Sleep Quality Survey, the Stanford Somnolence Scale, blood pressure, oxygen saturation, and heart rate, in addition to treatment-related adverse events were also captured. DISCUSSION: This trial aims to ascertain the therapeutic benefits of ETN in mitigating AMS symptoms, thereby contributing to the evidence base for traditional medical practices, particularly acupuncture, in high-altitude medicine. TRIAL REGISTRATION: Chinese Clinical Trials Registry: ChiCTR2300073882. Registered on 24 July 2023.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China.
- Institute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences, Beijing, China.
- Department of Preventive Medicine, Tibet University Medical College, Lhasa, Tibet, China.
- High Altitude Health Science Research Center of Tibet University, Lhasa, Tibet, China.
- Department of Logistics and Security, National Immigration Administration, Beijing, China. 690481191@qq.com.
- Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China. marie_liujia@163.com.
Förderung
- Basic Scientific Research Business Independent Selection Program of the China Academy of Chinese Medical Sciences
- The Science and Technology Innovation Project of China Academy of Chinese Medical Sciences
- The National Key Research and Development Program of China
Zitieren
APA
Wang, X., Wang, G., Jia, S., Labasangzhu, L., Wang, Z., & Liu, J. (2024). Safety and efficacy of electro-thumbtack needle for acute mountain sickness patients: a protocol of a randomized, single-blinded, and placebo-controlled study. BMC Complementary Medicine and Therapies. https://doi.org/10.1186/s12906-024-04655-3
Vancouver
Wang X, Wang G, Jia S, Labasangzhu L, Wang Z, Liu J. Safety and efficacy of electro-thumbtack needle for acute mountain sickness patients: a protocol of a randomized, single-blinded, and placebo-controlled study. BMC Complementary Medicine and Therapies. 2024. doi:10.1186/s12906-024-04655-3
BibTeX
@article{Wang2024,
author = {Wang, Xin and Wang, GuangJun and Jia, ShuYong and Labasangzhu, Labasangzhu and Wang, Zirong and Liu, Jia},
title = {Safety and efficacy of electro-thumbtack needle for acute mountain sickness patients: a protocol of a randomized, single-blinded, and placebo-controlled study},
journal = {BMC Complementary Medicine and Therapies},
year = {2024},
doi = {10.1186/s12906-024-04655-3}
}
EUVIMED